Who owns APELLIS PHARMACEUTICALS INC?
- CUSIP Number: 03753uab2
Tip: Access positions for across all investors
Analyze quarterly positions in Apellis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apellis Pharmaceuticals stock
Who bought or sold APELLIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DeepCurrents Investment Group | 41M | $66M | 3% | Dec 2023 |
|
| Lazard Asset Management | 16M | $26M | 30% | Dec 2023 |
|
| Wolverine Asset Management | 12M | $19M | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 5.0M | $8.2M | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 2.5M | $3.7M | 109% | Dec 2023 |
|
| Wellington Management Company | 1.3M | $2.1M | 0% | Dec 2023 |
|
| Palisade Capital Management | 1.0M | $1.7M | 0% | Dec 2023 |
|
| Citigroup | 504k | $821k | 0% | Dec 2023 |
|
| Kornitzer Capital Management | 300k | $489k | 0% | Dec 2023 |
|